Lee LH

References (3)

Title : White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease - Lee_2023_PLoS.One_18_e0283790
Author(s) : Lee LH , Wu SC , Ho CF , Liang WL , Liu YC , Chou CJ
Ref : PLoS ONE , 18 :e0283790 , 2023
Abstract : Lee_2023_PLoS.One_18_e0283790
ESTHER : Lee_2023_PLoS.One_18_e0283790
PubMedSearch : Lee_2023_PLoS.One_18_e0283790
PubMedID: 37000849

Title : Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer's Disease Management - Bakrim_2022_Molecules_27_
Author(s) : Bakrim S , Aboulaghras S , El Menyiy N , El Omari N , Assaggaf H , Lee LH , Montesano D , Gallo M , Zengin G , AlDhaheri Y , Bouyahya A
Ref : Molecules , 27 : , 2022
Abstract : Bakrim_2022_Molecules_27_
ESTHER : Bakrim_2022_Molecules_27_
PubMedSearch : Bakrim_2022_Molecules_27_
PubMedID: 36558176

Title : Health Benefits and Pharmacological Properties of Stigmasterol - Bakrim_2022_Antioxidants.(Basel)_11_
Author(s) : Bakrim S , Benkhaira N , Bourais I , Benali T , Lee LH , El Omari N , Sheikh RA , Goh KW , Ming LC , Bouyahya A
Ref : Antioxidants (Basel) , 11 : , 2022
Abstract : Bakrim_2022_Antioxidants.(Basel)_11_
ESTHER : Bakrim_2022_Antioxidants.(Basel)_11_
PubMedSearch : Bakrim_2022_Antioxidants.(Basel)_11_
PubMedID: 36290632